MedPath

A study to assess the effectof Withania Somnifera on physical performance, blood parameters of inflammation and muscle status in healthy individuals.

Phase 1
Registration Number
CTRI/2019/07/020278
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Male and female, 18 to 30 years

2. Volunteers with normal health status which will be assessed by below mentioned investigations.

1) Clinical history and physical examination

2) Hematological: Hb, CBC within 10% of the normal range detected at screening

3) Biochemical: Serum SGOT, SGPT & Serum BUN and Serum Creatinine, FBS, S.LDL, S. Cholesterol, S. Triglycerides within 1.5 times upper limit of normal range detected at screening.

3. Volunteers ready to refrain from unaccustomed strenuous physical activity and follow constant diet pattern at least one week before starting the study & throughout the study duration & those who do not drink & smoke (at least for past six months)

4. Volunteers with no h/o any lower limb or upper limb injury within past six months or co-morbid condition, underwent surgical procedure wherein exercise is contraindicated.

5. Volunteers ready to abide by trial procedures and to give a written informed consent.

Exclusion Criteria

1. Volunteers with h/o of allergy or intolerance to herbal drugs or anaphylactic reaction

2. Volunteers with h/o intake of traditional systems of medicine including drugs with Rasayana properties in the past 4 weeks.

3. Volunteers with BMI less than 23 or more than 30.

4. Pregnant and lactating woman.

5. Volunteers taking anabolic steroids, protein supplements or other nutritional supplements, vitamins, anti oxidants for more than 5 days on contionous basis and use of any recreational drug or a history of drug addiction.

6. Volunteers with known cardiovascular, musculoskeletal, hepatobiliary, genitourinary, neurological or any psychiatric condition.

7. Volunteers on any chronic medication ( > 2weeks in the last six months)

8. Volunteers who have recently joined gymnasium in past one month and are doing active resistance exercises.

9. Volunteer participating in another investigational drug trial in the previous 30 days.

10. Volunteers who cannot give valid consent such as mentally retarded or with psychiatric illness.

11. Volunteers with documented h/o positive screening result for hepatitis B and/or hepatitis C virus and documented h/o HIV or any immune deficient conditions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Statistical significant change in level of biomarkers of muscle status and inflammation in response to exercise (based on serum CPK, serum LDH, serum myostatin, IL-6, hs-CRP, TNF - α) in volunteers administered Withania somnifera.Timepoint: On day (-3) and day 60.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath